- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
On this final Oncology Onward episode of 2023, cohosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, talk with Penn Medicine’s Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation. Their conversation encapsulates much of what has been discussed in the oncology space in the past year, from the unique perspective of academic medicine: the importance of collaboration between academic medical centers and community oncology practices and testing innovative cancer care delivery in academic and community settings to have the greatest impact on patients.
“If we can only show that a certain innovation works at Penn Medicine or an academic practice, it's very limited—it's useful, but it's very limited,” Bekelman says. “If we want to demonstrate as part of our mandate to generalize knowledge across the country, we have to be able to extend programs into the community, learn from the community, test things that are working in the community in academic environments, create a bidirectional approach that allows for expertise from both systems to create the best possible opportunities for patients with cancer.”
For interview audio:
Listen above or on one of these podcast services:
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
New Research Links Gender, Racial Microaggressions to Higher Postpartum Blood Pressure
January 9th 2025Acts of discrimination, including subtle microaggressions, during pregnancy and childbirth contribute to higher maternal mortality rates, especially among Black women, and are linked to increased postpartum blood pressure, highlighting the need for improved health care interventions and racial equity in maternity care.
Read More
